| Current Price | $196.28 | Mkt Cap | $9.9B |
|---|---|---|---|
| Open | $194.00 | P/E Ratio | 20.01 |
| Prev. Close | $193.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $190.43 - $196.96 | Volume | 259,760 |
| 52-Wk Range | $181.22 - $262.00 | Avg. Daily Vol. | 563,565 |
The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.
| Current Price | $196.28 | Mkt Cap | $9.9B |
|---|---|---|---|
| Open | $194.00 | P/E Ratio | 20.01 |
| Prev. Close | $193.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $190.43 - $196.96 | Volume | 259,760 |
| 52-Wk Range | $181.22 - $262.00 | Avg. Daily Vol. | 563,565 |
Read the most recent pitches from players about CRL.
Recs
TMFTripleOption
(< 20)
Submitted: 4/21/2020 11:15:59 PM :
Start Price:
$135.30
NYSE:CRL Score:
-6.79
Charles River Labs had its hand in 90% of FDA approved drugs last year. They are also building a lot of labs in China. Their demand will only continue to grow.
Recs
CMFTomato
(59.49)
Submitted: 12/15/2019 4:28:09 PM :
Start Price:
$123.48
NYSE:CRL Score:
+13.05
Charles River breeds and sells lab rats, mice, bunnies, guinea pigs of all shapes and sizes and in various states of sickness, health, obesity, and even already having had various clinical procedures and operations. This company's work is unpleasant, but essential for the clinical trials and research behind the groundbreaking treatments and therapies that allow us to live longer and healthier.
Recs
kenjotto
(< 20)
Submitted: 8/10/2011 10:16:21 AM :
Start Price:
$30.59
NYSE:CRL Score:
+266.31
Activist inspired turn around is progressing well. They're repurchasing shares, cutting underperforming segments, and increasing and improving their sales to key end users. As big pharma looks to revive its pipeline, they'll come to CRL. Plus, CRL is only #2 in the CRO industry, so they have runway ahead of them!
Find the members with the highest scoring picks in CRL.
tskephart (91.85) Score: +399.36
The Score Leader is the player with the highest score across all their picks in CRL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| tskephart | 91.85 | 11/26/2008 |
|
3Y | $21.87 | +794.19% | +394.84% | +399.36 | 1 Comment | |
| dingo72 | 78.67 | 12/3/2008 |
|
3Y | $21.94 | +791.34% | +402.62% | +388.72 | 0 Comment | |
| 5st4 | 87.66 | 1/9/2009 |
|
NS | $23.91 | +717.90% | +370.24% | +347.66 | 0 Comment | |
| DFT2007 | 99.75 | 11/17/2008 |
|
NS | $23.35 | +737.52% | +400.27% | +337.25 | 0 Comment | |
| jackjjr | 71.73 | 11/17/2011 |
|
5Y | $28.96 | +575.28% | +241.81% | +333.47 | 0 Comment | |
| dog1350 | 71.11 | 12/11/2008 |
|
5Y | $24.17 | +709.10% | +382.60% | +326.50 | 0 Comment | |
| kagold | 84.44 | 10/4/2011 |
|
5Y | $27.68 | +606.50% | +288.75% | +317.75 | 0 Comment | |
| elzbal | < 20 | 10/17/2011 |
|
1Y | $29.43 | +564.49% | +247.88% | +316.61 | 0 Comment | |
| JohnGabriel | 73.37 | 9/29/2011 |
|
5Y | $28.97 | +575.04% | +263.46% | +311.58 | 0 Comment | |
| CMFGouldberg | 37.01 | 10/3/2011 |
|
5Y | $28.18 | +593.97% | +283.16% | +310.80 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
